Digitalis and intractable heart failure.
نویسندگان
چکیده
منابع مشابه
شناسایی گلیکوزیدهای قلبی گونه دیژیتال ایران به روش HPLC
Background and Purpose: Digitalis species and their cardiac glycosides are used in congestive heart failure (ÇHF) disease. Digitalis nervosa are grown only in the North regions of Ïran. Çardiac glycosides of other species are identified by HPLÇ procedure. Ïn this research, cardiac glycosides of Digitalis nervosa were identified. Materials and Methods: Ïn this research, methanol as solvent ...
متن کاملGlucagon in heart failure and in cardiogenic shock. Experience in 50 patients.
Intravenous glucagon, in doses of 2.5-15 mg/hour, was administered to 50 patients for periods of 1-7 days. Forty patients had either intractable heart failure or cardiogenic shock or both; the remaining 10 had less severe heart disease. In all patients glucagon was added to conventional therapy. Twenty-two of the 40 with very severe heart failure showed a clinical improvement, and 18 were disch...
متن کاملGlueagon in Heart Failure and in Cardiogenic Shock
Intravenous glucagon, in doses of 2.5-15 mg/hour, was administered to 50 patients for periods of 1-7 days. Forty patients had either intractable heart failure or cardiogenic shock or both; the remaining 10 had less severe heart disease. In all patients glucagon was added to conventional therapy. Twenty-two of the 40 with very severe heart failure showed a clinical improvement, and 18 were disch...
متن کاملGlueagon in Heart Failure and in Cardiogenic Shock Experience in 50 Patients
Intravenous glucagon, in doses of 2.5-15 mg/hour, was administered to 50 patients for periods of 1-7 days. Forty patients had either intractable heart failure or cardiogenic shock or both; the remaining 10 had less severe heart disease. In all patients glucagon was added to conventional therapy. Twenty-two of the 40 with very severe heart failure showed a clinical improvement, and 18 were disch...
متن کاملThe contemporary use of digoxin for the treatment of heart failure.
The use of digitalis has been plagued by controversy since its initial use by Withering in 1775. We now have much more data,1 but it should be remembered that the Digitalis Investigator Group trial was executed when -blockers were not widely used to treat heart failure. There are still many questions about where we currently stand with the use of digitalis. Specifically, when should one add dig...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- British heart journal
دوره 20 2 شماره
صفحات -
تاریخ انتشار 1958